share_log

Wedbush Initiates Coverage On Tyra Biosciences With Outperform Rating, Announces Price Target of $27

Benzinga ·  Jun 30, 2023 04:55

Wedbush analyst Robert Driscoll initiates coverage on Tyra Biosciences (NASDAQ:TYRA) with a Outperform rating and announces Price Target of $27.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment